Abstract: Provided is a composition for preventing, alleviating or treating dry eye syndrome, containing an Aucuba japonica extract as an active ingredient. The composition containing an Aucuba japonica extract can be effectively used in the prevention, alleviation or treatment of dry eye syndrome.

Abstract: A method and system for certifying a low-carbon product using slaughter traceability information is disclosed. The method can be performed in a system for performing certification for a livestock product of a target subject, including obtaining reference carbon emission information which is information related to the average daily carbon emission of a reference group, by using slaughter traceability information of the reference group which is a group of the same livestock type of subjects as the target subject; deriving target carbon emission information which is information related to the amount of carbon emission per weight of the target subject, by using the slaughter traceability information of the target subject and the reference carbon emission information obtained in advance; and certifying the livestock product of the target subject as a low-carbon certified livestock product, when the value of the target carbon emission information decreases below a reference value.

Abstract: A method and system for reducing greenhouse gas using livestock genomic information is disclosed.

Abstract: A diacetylene-based lyotropic liquid crystal mixture according to an embodiment includes by mixing diacetylene-based compounds containing iodide and triiodide Chemical Formula 1 and Chemical Formula 2. The lyotropic liquid crystal mixture may be prepared by synthesizing an [X]—C—Rm-[D]-Rn compound, synthesizing an [A+X?]—C—Rm-D-Rn compound, and synthesizing an [A+B?]—C—Rm-D-Rn compound. A thin polarizing film may be prepared through simple coating of a lyotropic liquid crystal mixture prepared by mixing diacetylene-based compounds containing iodide and triiodide.

Abstract: The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.

Abstract: The present disclosure relates to a cold and hot thermal treatment device. Hot heat and cold heat are produced by a heat production unit and are periodically and repeatedly transferred to a heat transfer unit that is in contact with a human body such that a temperature is not suddenly changed but is gradually changed. Thus, the device may be used when diagnosing whether vascular reactivity is maintained in corresponding hands and feet, may generate a temperature stimulus, and may repeatedly perform the temperature stimulus, thereby improving the vascular reactivity.

Abstract: The present disclosure relates to a pharmaceutical composition containing an inhibitor against the expression or activation of a novel ADP-ribosyl cyclase or a naturally occurring variant thereof as an active ingredient for preventing or treating an ADP-ribosyl cyclase-mediated disease. In addition, the present disclosure relates to a composition for diagnosis of an ADP-ribosyl cyclase-mediated disease, the composition containing an agent for measuring a gene expression level or protein level of the ADP-ribosyl cyclase or a naturally occurring variant thereof. The composition of the present disclosure has the effect of inhibiting calcium increase in kidney cells, which is attributed to angiotensin II-induced ADP-ribosyl cyclase expression or activation, and as such can be advantageously used as a therapeutic agent for an ADP-ribosyl cyclase-mediated disease, particularly a renal disease.

Abstract: The present disclosure relates to a composition for preventing, alleviating or treating pruritus and/or atopy using an N-acetylamino acid or an N-acylamino acid having almost no side effects on the human body. Also, the present disclosure relates to a cosmetic composition for moisturizing skin or soothing skin. The composition of the present disclosure may be utilized to ameliorate a problematic skin condition caused by various causes, or to safely and effectively alleviate or treat pruritus and/or atopy without concern about side effects.

Abstract: The present inventive concepts relate to an inspection apparatus that snapshots an interference image pattern having a high spatial carrier frequency produced from a one-piece off-axis polarimetric interferometer and that precisely and promptly measures a Stokes vector including spatial polarimetric information. The inspection apparatus dynamically measure in real-time a two-dimensional polarization information without employing a two-dimensional scanner.

Abstract: Disclosed are a perovskite compound, a method for producing the perovskite compound, a catalyst for a fuel cell including the perovskite compound, and a method for producing the catalyst. The perovskite compound overcomes the low stability of palladium due to its perovskite structural properties. Therefore, the perovskite compound can be used as a catalyst material for a fuel cell. In addition, the use of palladium in the catalyst instead of expensive platinum leads to an improvement in the price competitiveness of fuel cells. The catalyst is highly durable and catalytically active due to its perovskite structure.

Abstract: The present invention relates to a respiratory sensing device attached to a patient's body and configured to acquire information regarding the patient's respiratory condition by sensing a vibration generated due to the patient's respiration using the piezoelectric effect and a respiratory monitoring system configured to output the acquired information regarding the patient's respiratory state.

Abstract: The present disclosure relates to a composition for preventing, improving or treating pruritus by using a naturally derived ingredient. The composition of the present disclosure may be used to improve or treat pruritus caused by various causes safely and effectively without the risk of side effects.

Abstract: A liquid crystal display device and a method of manufacturing a liquid crystal display device are provided. The liquid crystal display device includes: a base; an alignment inducing layer on the base and including a first compound represented by formula A1 or a polymer of the first compound; and a liquid crystal layer on the alignment inducing layer that includes liquid crystals: where R1 may be hydrogen or a polymerizable group, R2 may be a hydrophilic group, SP1 and SP2 may each independently be a single bond, a C1-C12 alkylene group, or a C1-C12 alkoxylene group, Z may be a single bond, an ester group, or an ether group, and X1, X2 and X3 may each independently be hydrogen, a methyl group, fluorine, or chlorine.

Abstract: Provided is a driving system and method for a wound rotor synchronous generator. The driving system for a wound rotor synchronous generator according to the present invention includes: a converter controlling the wound rotor synchronous generator and receiving generated power; and a field winding power supply means supplying the power to a field winding of a rotor of the generator. The field winding power supply means is connected to the converter to receive the power from the converter and supply the power to the field winding, the power supplied to the field winding being electrically insulated from the power received from the converter.

Abstract: When using a pharmaceutical composition for preventing or treating malignant hyperthermia, containing NAADP antagonists, of the present invention, malignant hyperthermia can be effectively prevented or treated through the inhibition of an oxygen consumption rate abnormal increase, which is associated with a ryanodine receptor (RYR) of skeletal muscles. In addition, the present invention can be used even after the onset of malignant hyperthermia and can inhibit an oxygen consumption rate abnormal increase even at concentrations lower than those of conventional agents for treating malignant hyperthermia, thereby enabling conventional agents for treating malignant hyperthermia to be replaced, and can be stably used, thereby being effectively usable in relevant industries.

Abstract: The present inventive concepts comprises linearly polarizing light, splitting the linearly polarized light into a first light and a second light, modulating the first light and the second light to have a phase difference to produce an output wave light, converting the output wave light to have a linear shape in a first direction to radiate the converted output wave light to a measured object, receiving a measurement light coming out of the measured object and linearly polarizing the first light and the second light of the measurement light to generate an interference light, and obtaining from the interference light an image of the measured object. The measured object can be scanned in a second direction intersecting the first direction or may be scanned rotationally about an axis in a third direction perpendicular to the first and second directions.

Abstract: A flexible liquid crystal film using a fiber-based foldable transparent electrode and a method of fabricating the same are provided. A flexible liquid crystal film using a fiber-based foldable transparent electrode according to an exemplary embodiment of the present disclosure, the flexible liquid crystal film includes: a pair of fiber-based foldable transparent electrodes in which a nanofiber transparent thin film formed of a polymer and a Nylon-6 nanofiber is coated with a silver (Ag) nanowire; and a dispersed liquid crystal formed by being cured between the pair of fiber-based foldable transparent electrodes.

Abstract: Provided is a composition for preventing, alleviating or treating dry eye syndrome, containing an Aucuba japonica extract as an active ingredient. The composition containing an Aucuba japonica extract can be effectively used in the prevention, alleviation or treatment of dry eye syndrome.

Abstract: A foldable transparent electrode based on fiber and a manufacturing method thereof are provided. The manufacturing method of a foldable transparent electrode based on fiber according to the exemplary embodiment includes: coating a nylon-6 nanofiber nonwoven fabric with a polymer to prepare a nylon-6 nanofiber transparent thin film, and spin coating the nylon-6 nanofiber transparent thin film with a silver nanowire solution.

Abstract: A method is disclosed including: allowing a contract research organization device to generate clinical trial information and transmit the information to a blockchain server; allowing the server to register the information, and assign a first private key and a first public key to a set site device and transmit the assigned keys to the site device in response to a request from the organization device; allowing the server to complete applicant authentication using a second private key assigned to an applicant for a clinical trial; allowing the site device to confirm previous participation information of the applicant; and allowing the site device to perform the clinical trial based on the previous participation information, encrypt a performance result of the clinical trial using the first public key, a second public key corresponding to the second private key, and the second private key, and transmit the encrypted performance result to the server.